Protein engineering 20 years on

It is 20 years since site-directed mutagenesis was first used to modify the active site of an enzyme of known structure and mechanism. Since then, this method has contributed far-reaching insights into catalysis, specificity, stability and folding of proteins. Engineered proteins are now being used in industry and for the improved treatment of human disease.

[1]  M. Bretscher,et al.  Membrane traffic during cell locomotion. , 1998, Current opinion in cell biology.

[2]  Dan S. Tawfik,et al.  Man-made enzymes--from design to in vitro compartmentalisation. , 2000, Current opinion in biotechnology.

[3]  W. Rutter,et al.  Selective alteration of substrate specificity by replacement of aspartic acid-189 with lysine in the binding pocket of trypsin. , 1987, Biochemistry.

[4]  Volker Sieber,et al.  Libraries of hybrid proteins from distantly related sequences , 2001, Nature Biotechnology.

[5]  J. Wells,et al.  Dissecting the catalytic triad of a serine protease , 1988, Nature.

[6]  H. Bayley,et al.  Stochastic sensors inspired by biology , 2001, Nature.

[7]  I. Sigal,et al.  Thiol-beta-lactamase: replacement of the active-site serine of RTEM beta-lactamase by a cysteine residue. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. Fersht,et al.  Mapping the transition state and pathway of protein folding by protein engineering , 1989, Nature.

[9]  D. Estell,et al.  Subtilisin--an enzyme designed to be engineered. , 1988, Trends in biochemical sciences.

[10]  L. Rossi-Bernardi,et al.  Interaction of hemoglobin with hydrogen ions, carbon dioxide, and organic phosphates. , 1973, Physiological reviews.

[11]  Marianne Manchester,et al.  Complete mutagenesis of the HIV-1 protease , 1989, Nature.

[12]  J. McCafferty,et al.  Engineering therapeutic proteins. , 2000, Current opinion in structural biology.

[13]  A. Fersht,et al.  Rational modification of enzyme catalysis by engineering surface charge , 1987, Nature.

[14]  P. T. Jones,et al.  Replacing the complementarity-determining regions in a human antibody with those from a mouse , 1986, Nature.

[15]  M. Weiss,et al.  STRUCTURE OF HEN EGG-WHITE LYSOZYME , 2000 .

[16]  H. Kagamiyama,et al.  Directed evolution of ampicillin-resistant activity from a functionally unrelated DNA fragment: A laboratory model of molecular evolution. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Winter,et al.  Phage antibodies: filamentous phage displaying antibody variable domains , 1990, Nature.

[18]  Hiroshi Murakami,et al.  Random insertion and deletion of arbitrary number of bases for codon-based random mutation of DNAs , 2002, Nature Biotechnology.

[19]  J. Olson,et al.  Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin , 1998, Nature Biotechnology.

[20]  A. Bershadsky,et al.  Pseudopodial activity at the active edge of migrating fibroblast is decreased after drug-induced microtubule depolymerization. , 1991, Cell motility and the cytoskeleton.

[21]  A. Fersht,et al.  Transition-state stabilization in the mechanism of tyrosyl-tRNA synthetase revealed by protein engineering. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R J Leatherbarrow,et al.  Structure-activity relationships in engineered proteins: analysis of use of binding energy by linear free energy relationships. , 1987, Biochemistry.

[23]  Richard Earl Dickerson,et al.  Hemoglobin : structure, function, evolution, and pathology , 1983 .

[24]  Iain D. Campbell,et al.  The march of structural biology , 2002, Nature Reviews Molecular Cell Biology.

[25]  B. Matthews,et al.  Genetic and structural analysis of the protein stability problem. , 1987, Biochemistry.

[26]  A. Riggs,et al.  Oligonucleotide-directed mutagenesis as a general and powerful method for studies of protein function. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Daisuke Kiga,et al.  An engineered Escherichia coli tyrosyl–tRNA synthetase for site-specific incorporation of an unnatural amino acid into proteins in eukaryotic translation and its application in a wheat germ cell-free system , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  X. Soberón,et al.  Novel ceftazidime-resistance beta-lactamases generated by a codon-based mutagenesis method and selection. , 2002, Nucleic acids research.

[29]  T. Poulos,et al.  Site-directed mutagenesis and the role of the oxyanion hole in subtilisin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Design of a specific phenyllactate dehydrogenase by peptide loop exchange on the Bacillus stearothermophilus lactate dehydrogenase framework. , 1992, Biochemistry.

[31]  W. Stemmer,et al.  DNA shuffling of a family of genes from diverse species accelerates directed evolution , 1998, Nature.

[32]  S. Benkovic,et al.  Rapid generation of incremental truncation libraries for protein engineering using alpha-phosphothioate nucleotides. , 2001, Nucleic acids research.

[33]  S. Sligar,et al.  Discrimination between oxygen and carbon monoxide and inhibition of autooxidation by myoglobin. Site-directed mutagenesis of the distal histidine. , 1989, The Journal of biological chemistry.

[34]  Martin Lehmann,et al.  The consensus concept for thermostability engineering of proteins: further proof of concept. , 2002, Protein engineering.

[35]  F. Arnold.  Engineering enzymes for non-aqueous solvents. , 1990, Trends in biotechnology.

[36]  A. Fersht,et al.  Site-directed mutagenesis as a probe of enzyme structure and catalysis: tyrosyl-tRNA synthetase cysteine-35 to glycine-35 mutation. , 1983, Biochemistry.

[37]  Frances H. Arnold,et al.  Design by Directed Evolution. , 1998 .

[38]  F. Arnold,et al.  Tuning the activity of an enzyme for unusual environments: sequential random mutagenesis of subtilisin E for catalysis in dimethylformamide. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Jennifer L. Ong,et al.  Directed evolution of polymerase function by compartmentalized self-replication , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Vølund,et al.  Insulin analogs with improved pharmacokinetic profiles. , 1999, Advanced drug delivery reviews.

[41]  D Zicha,et al.  Rapid, microtubule-dependent fluctuations of the cell margin. , 1997, Journal of cell science.

[42]  J. Wells,et al.  High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. , 1989, Science.

[43]  J. Knowles,et al.  Perfection in enzyme catalysis: the energetics of triosephosphate isomerase , 1977 .

[44]  Tom L. Blundell,et al.  Insulin: The Structure in the Crystal and its Reflection in Chemistry and Biology by , 1972 .

[45]  P. Holliger,et al.  Engineering Antibodies for the Clinic , 2004, Cancer and Metastasis Reviews.

[46]  T. W. Love,et al.  Recombinant antibodies possessing novel effector functions. , 1989, Methods in enzymology.

[47]  B. Cunningham,et al.  Importance of hydrogen-bond formation in stabilizing the transition state of subtilisin , 1986, Philosophical Transactions of the Royal Society of London. Series A, Mathematical and Physical Sciences.

[48]  H. Wilks,et al.  Designs for a broad substrate specificity keto acid dehydrogenase. , 1990, Biochemistry.

[49]  M. Perutz.  Stereochemistry of Cooperative Effects in Haemoglobin: Haem–Haem Interaction and the Problem of Allostery , 1970, Nature.

[50]  J. Whittingham,et al.  Crystal structure of a prolonged-acting insulin with albumin-binding properties. , 1997, Biochemistry.

[51]  Marc T. Facciotti,et al.  Improved stearate phenotype in transgenic canola expressing a modified acyl-acyl carrier protein thioesterase , 1999, Nature Biotechnology.

[52]  A. Fersht,et al.  Hydrogen bonding and biological specificity analysed by protein engineering , 1985, Nature.

[53]  L. J. Perry,et al.  Disulfide bond engineered into T4 lysozyme: stabilization of the protein toward thermal inactivation. , 1984, Science.

[54]  W. Rutter,et al.  Structural origins of substrate discrimination in trypsin and chymotrypsin. , 1995, Biochemistry.

[55]  H. Muirhead,et al.  A specific, highly active malate dehydrogenase by redesign of a lactate dehydrogenase framework. , 1988, Science.

[56]  R. Winslow.  Blood substitutes: refocusing an elusive goal. Review , 2000 .

[57]  W. Lipscomb,et al.  Escherichia coli aspartate transcarbamylase: the relation between structure and function. , 1988, Science.

[58]  K. Struhl,et al.  An efficient method for generating proteins with altered enzymatic properties: application to beta-lactamase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Olson,et al.  Protein engineering strategies for designing more stable hemoglobin-based blood substitutes. , 1997, Artificial cells, blood substitutes, and immobilization biotechnology.

[60]  Frances H. Arnold,et al.  Exploring Nonnatural Evolutionary Pathways by Saturation Mutagenesis: Rapid Improvement of Protein Function , 1999, Journal of Molecular Evolution.

[61]  P. Schultz,et al.  Directed evolution of novel polymerase activities: Mutation of a DNA polymerase into an efficient RNA polymerase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[62]  G. Winter,et al.  A model of synthetase/transfer RNA interaction as deduced by protein engineering , 1986, Nature.

[63]  C D Maranas,et al.  Creating multiple-crossover DNA libraries independent of sequence identity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[64]  F. Bolivar,et al.  A general, PCR-based method for single or combinatorial oligonucleotide-directed mutagenesis on pUC/M13 vectors. , 1992, BioTechniques.

[65]  A. Fersht,et al.  A large increase in enzyme–substrate affinity by protein engineering , 1984, Nature.

[66]  M. Perutz.  Stereochemistry of cooperative effects in haemoglobin. , 1970, Nature.

[67]  G. Vriend,et al.  Engineering an enzyme to resist boiling. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Paul E O'Maille,et al.  Structure-based combinatorial protein engineering (SCOPE). , 2002, Journal of Molecular Biology.

[69]  P G Schultz,et al.  Expanding the Genetic Code of Escherichia coli , 2001, Science.

[70]  W. Stemmer,et al.  Evolution of a cytokine using DNA family shuffling , 1999, Nature Biotechnology.

[71]  W. Stemmer.  DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[72]  K. Nagai,et al.  A human recombinant haemoglobin designed for use as a blood substitute , 1992, Nature.

[73]  A. Fersht,et al.  Protein Folding and Unfolding at Atomic Resolution , 2002, Cell.

[74]  G. Winter,et al.  The binding site for C1q on IgG , 1988, Nature.

[75]  R. Winslow.  Blood substitutes: refocusing an elusive goal , 2000, British journal of haematology.

[76]  W. Kiosses,et al.  Regulation of the small GTP‐binding protein Rho by cell adhesion and the cytoskeleton , 1999, The EMBO journal.

[77]  K. Kaibuchi,et al.  Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. , 2001, Trends in pharmacological sciences.

[78]  J. Knowles.  Tinkering with enzymes: what are we learning? , 1987, Science.

[79]  John M Woodley,et al.  The search for the ideal biocatalyst , 2002, Nature Biotechnology.

[80]  D. Shortle,et al.  Probing the determinants of protein folding and stability with amino acid substitutions. , 1989, The Journal of biological chemistry.

[81]  Alan R. Fersht,et al.  Redesigning enzyme structure by site-directed mutagenesis: tyrosyl tRNA synthetase and ATP binding , 1982, Nature.

[82]  J. Wells,et al.  Additivity of mutational effects in proteins. , 1990, Biochemistry.

[83]  J. Brange,et al.  Monomeric insulins obtained by protein engineering and their medical implications , 1988, Nature.

[84]  H. Suenaga,et al.  Enhanced degradation of polychlorinated biphenyls by directed evolution of biphenyl dioxygenase , 1998, Nature Biotechnology.

[85]  W. Rutter,et al.  Site-directed mutagenesis shows that tyrosine 248 of carboxypeptidase A does not play a crucial role in catalysis , 1985, Nature.

[86]  W. Stemmer.  Rapid evolution of a protein in vitro by DNA shuffling , 1994, Nature.

[87]  E. Salmon,et al.  Microtubule growth activates Rac1 to promote lamellipodial protrusion in fibroblasts , 1999, Nature Cell Biology.

[88]  S. Withers,et al.  Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate , 2001, Nature.

[89]  P. Schultz,et al.  MUTAGENESIS WITH AN EXPANDED GENETIC CODE , 1995 .

[90]  César Milstein,et al.  Man-made antibodies , 1991, Nature.

[91]  P. Schultz,et al.  Site-directed mutagenesis with an expanded genetic code. , 1995, Annual review of biophysics and biomolecular structure.

[92]  M. Smith,et al.  In vitro mutagenesis. , 1985, Annual review of genetics.

[93]  W. Rutter,et al.  Attempts to convert chymotrypsin to trypsin. , 1996, FEBS letters.

[94]  C. Hutchison,et al.  Mutagenesis at a specific position in a DNA sequence. , 1978, The Journal of biological chemistry.

[95]  A. Fersht.  Enzyme structure and mechanism , 1977 .

[96]  W. Duckworth,et al.  Genetically engineered insulin analogs: diabetes in the new millenium. , 2000, Pharmacological reviews.